Fig. 7From: PROX1 and β-catenin are prognostic markers in pancreatic ductal adenocarcinomaConcomitant positivity by β-catenin and PROX1. Cancer-specific survival analysis according to the Kaplan-Meier method for combined expression of β-catenin and PROX1. A categorization of three classes was created to study the two markers together: low (β-catenin, and PROX1, low), moderate (either β-catenin, or PROX1 high), and high (β-catenin, and PROX1 high)Back to article page